Prostate Cancer: Slowing Down Its Development by William J.
Catalona, M.D.

Although prostate cancer is influenced by both heredity and
environmental
factors, some measures might prevent the development or slow the
progression
of prostate cancer.
Prostate cancer is almost certainly caused by
changes (mutations) in the DNA that affect the regulation of the growth
of normal prostate cells. Most probably, several mutations have to
take place before a full-blown cancer occurs. These mutations can
accumulate over time, causing the gradual progression to prostate
cancer. Some mutations may cause a precancerous condition called
prostatic
intraepithelial neoplasia (PIN); others may cause a slowly
growing form of
the cancer; and still others may cause a rapidly progressive form of the
disease. Some prostate cancers may take decades to develop, while
others may develop more rapidly if a more serious mutation occurs.
A man may inherit one or more of these mutations from either
their mothers or
their fathers. In these cases, fewer additional mutations would be needed
before cancer occurs. Even with these mutations, recent attention has been
focused on nutrients as possible prostate cancer preventive agents.
The
most promising are soy products (called phytoestrogens and
isoflavones), lycopene, vitamin E, selenium, and vitamin D.
Soy Products
Some researchers have speculated that the high ingestion of
soy products is responsible for the lower death rate from prostate cancer
in Japan (4 to 5 times lower than in the United States).
In
addition, some studies have suggested that prostate cancers
develop and
progress more slowly in Japan.
Soy has been shown to
slow the
proliferation of prostate cells, and part of this effect may be mediated
through lowering the levels of male hormones. Soy contains steroid-like
chemicals that may alter the chemical reactions in prostate tissues.
Soy proteins are changed by intestinal bacteria to produce
estrogenic and
antiestrogenic compounds. This production increases the levels of
binding
protein levels in the blood that tie up the male hormone,
testosterone, which
normally stimulates prostate cancer cells to grow.
Soy proteins also
have numerous other potential actions. They alter enzyme functions, alter
protein synthesis, alter the action of growth factors, directly affect the
growth rate of prostate cells, and alter the production of blood vessels that
allow tumors to grow.
Genistein, one of the most prominent components
in soy, has been shown in animal prostate cancers to slow the rate of
tumor growth.
Sufficient experimental evidence justifies the use of
soy proteins in clinical trials for preventing prostate cancer, and
these studies will provide important information in the
future.
Lycopene
Lycopene, found in tomato products, has one of the
greatest capacities for preventing mutations in DNA. Chemicals that have
these properties are called antioxidants, and lycopene is one of the
stronger antioxidants. In addition, lycopene has other biological
activities for cell to cell communications and growth control. Experimental
animal studies show that lycopene can slow the growth of prostate cancer
cells.
Epidemiologic studies (studies that deal with the
incidence, distribution and control of disease in a population) have shown
that consumption of lycopene is associated with a lower risk of
prostate cancer. In one important study, lycopene was the only
antioxidant found in significantly lower levels in prostate cancer patients
than in men without prostate cancer. Also, other studies suggest that
taking lycopene before prostate cancer surgery may result in more favorable
treatment results.
Lycopene concentrates are available at pharmacies and
health food stores and can be purchased over the counter without
a prescription.
Vitamin E
Vitamin E is a fat soluble
vitamin that also has the potential to decrease DNA damage through its
antioxidant effects. In addition, vitamin E affects the immune system.
Vitamin E deficiency is associated with decreased immune function which
increases the susceptibility to cancer and infections.
Vitamin E may not
only prevent the development of prostate cancer but also may slow its
progression, especially in smokers. Vitamin E may also lower the activity
of some cellular signals that increase cell
growth. Studies suggest that
vitamin E may be especially important in inhibiting the growth of prostate
cancer cells induced by a high-fat diet.
Many fat soluble vitamins
such as vitamin E can cause side effects if taken in large doses. Some
(but not all) studies suggest that too much vitamin E may interfere with
blood coagulation and lead to post-surgery bleeding due to its effect on
platelet function.
Vitamin E exists in several
forms; 200 to 800 units of
the alpha tocopherol form of vitamin E are well tolerated.
Selenium
Selenium may also act as an anticancer agent due to its
antioxidant properties. Selenium suppresses cell growth and enhances the immune
response, thus functioning similarly to vitamin E.
Studies have
suggested that prostate cancer risk was reduced by 60% among those who take
supplemental selenium.
Selenium may also exert its antitumor effects by
other mechanisms, such as inducing programmed death in cancer cells,
and affecting important enzyme systems.
The recommended dose of
selenium is 200 ug/day (ug. is a microgram or 1/1000 of a gram.) which is 2
to 3 times the recommended daily allowance.
Vitamin
D
While, vitamin D is important primarily for bone and mineral
metabolism,
it also induces conversion of prostate cancer cells into
normal cells and blocks the growth of prostate cancer cells.
Vitamin D may act by blocking
the progression of cells through the cell cycle and initiating programmed
cancer cell death. Vitamin D may be important in preventing prostate cancer
and is also being studied as an agent for the treatment of
advanced
prostate cancer.
The recommended daily dose is 10 ug/day. Higher doses
may cause high blood calcium levels.
|